The dynamics of Autism Spectrum Disorders: How neurotoxic compounds and neurotransmitters interact

International Journal of Environmental Research and Public Health

Volumn 10, Issue 8, 2013, Pages 3384-3408

  Quaak, Ilona ^a   Brouns, Madeleine R ^a   van de Bor, Margot ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

ASD; Autism spectrum disorder; Dopamine; GABA; Glutamate; Neurotoxic exposure; Neurotransmitter; Organochlorine; Organophosphate; Phthalate; Serotonin

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; CHLORPHENOTANE; CHLORPYRIFOS; DICHLORVOS; DICOFOL; DIELDRIN; DIMPYLATE; ENDOSULFAN; ENDOSULFAN SULFATE; GLUTAMIC ACID; LINDANE; METHAMIDOPHOS; METHOXYCHLOR; MONOCROTOPHOS; NEUROTRANSMITTER; PARAOXON; PARATHION METHYL; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIBUTYL ESTER; POLYCHLORINATED BIPHENYL; SULFATE; TRICHLOROETHYLENE; UNCLASSIFIED DRUG;

HEALTH IMPACT; MENTAL HEALTH; NEUROLOGY; ORGANOCHLORINE; ORGANOPHOSPHATE; PHTHALATE; POLLUTION EXPOSURE; TOXIC MATERIAL;

4 AMINOBUTYRIC ACID RELEASE; 4 AMINOBUTYRIC ACID UPTAKE; AUTISM; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; GABA B RECEPTOR 1 GENE; GABAERGIC SYSTEM; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR INTERACTION; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; RECEPTOR DOWN REGULATION; RECEPTOR GENE; RECEPTOR UPREGULATION; REVIEW; SEROTONINERGIC SYSTEM; TOXICITY TESTING;

EID: 84881259785     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph10083384     Document Type: Review

References (115)

1. Blumberg, S.J.; Bramlett, M.D.; Kogan, M.D.; Schieve, L.A.; Jones, J.R.; Lu, M.C. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. Children: 2007 to 2011-2012. Natl. Health Stat. Rep. 2013. Available online: http://www.cdc.gov/nchs/data/nhsr/ nhsr065.pdf (accessed on 10 April 2013).
2. Brugha, T.S.; McManus, S.; Bankart, J.; Scott, F.; Purdon, S.; Smith, J.; Bebbington, P.; Jenkins, R.; Meltzer, H. Epidemiology of autism spectrum disorders in adults in the community in England. Arch. Gen. Psychiatry 2011, 68, 459-465.
3. Baron-Cohen, S.; Scott, F.J.; Allison, C.; Williams, J.; Bolton, P.; Matthews, F.E.; Brayne, C. Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiatry 2009, 194, 500-509.
4. Nygren, G.; Cederlund, M.; Sandberg, E.; Gillstedt, F.; Arvidsson, T.; Carina Gillberg, I.; Westman Andersson, G.; Gillberg, C. The prevalence of autism spectrum disorders in toddlers: A population study of 2-year-old swedish children. J. Autism Dev. Disord. 2012, 42, 1491-1497.
5. Blaxill, M.F. What's going on? The question of time trends in autism. Public Health Rep. 2004, 119, 536-551.
6. Wang, K.; Zhang, H.; Ma, D.; Bucan, M.; Glessner, J.T.; Abrahams, B.S.; Salyakina, D.; Imielinski, M.; Bradfield, J.P.; Sleiman, P.M.; et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459, 528-533.
7. Hallmayer, J.; Cleveland, S.; Torres, A.; Phillips, J.; Cohen, B.; Torigoe, T.; Miller, J.; Fedele, A.; Collins, J.; Smith, K.; et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 2011, 68, 1095-1102.
8. Glessner, J.T.; Wang, K.; Cai, G.; Korvatska, O.; Kim, C.E.; Wood, S.; Zhang, H.; Estes, A.; Brune, C.W.; Bradfield, J.P.; et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459, 569-573.
9. Xu, L.M.; Li, J.R.; Huang, Y.; Zhao, M.; Tang, X.; Wei, L. Autismkb: An evidence-based knowledgebase of autism genetics. Nucleic Acids Res. 2012, 40, D1016-D1022.
10. Stamou, M.; Streifel, K.M.; Goines, P.E.; Lein, P.J. Neuronal connectivity as a convergent target of gene x environment interactions that confer risk for autism spectrum disorders. Neurotoxicol. Teratol. 2013, 36, 3-16.
11. Hertz-Picciotto, I.; Delwiche, L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20, 84-90.
12. Herbert, M.R. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr. Opin. Neurol. 2010, 23, 103-110.
13. Grandjean, P.; Landrigan, P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368, 2167-2178.
14. Wayman, G.A.; Bose, D.D.; Yang, D.; Lesiak, A.; Bruun, D.; Impey, S.; Ledoux, V.; Pessah, I.N.; Lein, P.J. Pcb-95 modulates the calcium-dependent signaling pathway responsible for activity-dependent dendritic growth. Environ. Health Perspect. 2012, 120, 1003-1009.
15. Schultz, S.T.; Klonoff-Cohen, H.S.; Wingard, D.L.; Akshoomoff, N.A.; Macera, C.A.; Ji, M. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey. Autism 2008, 12, 293-307.
16. Gould, G.G.; Seillier, A.; Weiss, G.; Giuffrida, A.; Burke, T.F.; Hensler, J.G.; Rock, C.; Tristan, A.; McMahon, L.R.; Salazar, A.; et al. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 38, 260-269.
17. Schultz, S.T. Can autism be triggered by acetaminophen activation of the endocannabinoid system? Acta Neurobiol. Exp. (Wars) 2010, 70, 227-231.
18. Siniscalco, D.; Sapone, A.; Giordano, C.; Cirillo, A.; de Magistris, L.; Rossi, F.; Fasano, A.; Bradstreet, J.J.; Maione, S.; Antonucci, N. Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J. Autism Dev. Disord. 2013, doi: 10.1007/s10803-013-1824-9.
19. Bouchard, M.F.; Chevrier, J.; Harley, K.G.; Kogut, K.; Vedar, M.; Calderon, N.; Trujillo, C.; Johnson, C.; Bradman, A.; Barr, D.B.; et al. Prenatal exposure to organophosphate pesticides and iq in 7-year-old children. Environ. Health Perspect. 2011, 119, 1189-1195.
20. Engel, S.M.; Wetmur, J.; Chen, J.; Zhu, C.; Barr, D.B.; Canfield, R.L.; Wolff, M.S. Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ. Health Perspect. 2011, 119, 1182-1188.
21. Rauh, V.A.; Garfinkel, R.; Perera, F.P.; Andrews, H.F.; Hoepner, L.; Barr, D.B.; Whitehead, R.; Tang, D.; Whyatt, R.W. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006, 118, e1845-e1859.
22. Eskenazi, B.; Marks, A.R.; Bradman, A.; Harley, K.; Barr, D.B.; Johnson, C.; Morga, N.; Jewell, N.P. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect. 2007, 115, 792-798.
23. De Cock, M.; Maas, Y.G.; van de Bor, M. Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders? Review. Acta Paediatr. 2012, 101, 811-818.
24. Roberts, E.M.; English, P.B.; Grether, J.K.; Windham, G.C.; Somberg, L.; Wolff, C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California central valley. Environ. Health Perspect. 2007, 115, 1482-1489.
25. Newbold, R.R. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 2010, 9, 206-217.
26. Slotkin, T.A. Cholinergic systems in brain development and disruption by neurotoxicants: Nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 2004, 198, 132-151.
27. Sunol, C.; Babot, Z.; Fonfria, E.; Galofre, M.; Garcia, D.; Herrera, N.; Iraola, S.; Vendrell, I. Studies with neuronal cells: From basic studies of mechanisms of neurotoxicity to the prediction of chemical toxicity. Toxicol. In Vitro 2008, 22, 1350-1355.
28. Fatemi, S.H.; Aldinger, K.A.; Ashwood, P.; Bauman, M.L.; Blaha, C.D.; Blatt, G.J.; Chauhan, A.; Chauhan, V.; Dager, S.R.; Dickson, P.E.; et al. Consensus paper: Pathological role of the cerebellum in autism. Cerebellum 2012, 11, 777-807.
29. Harada, M.; Taki, M.M.; Nose, A.; Kubo, H.; Mori, K.; Nishitani, H.; Matsuda, T. Non-invasive evaluation of the gabaergic/glutamatergic system in autistic patients observed by mega-editing proton MR spectroscopy using a clinical 3 tesla instrument. J. Autism Dev. Disord. 2011, 41, 447-454.
30. Hogart, A.; Leung, K.N.; Wang, N.J.; Wu, D.J.; Driscoll, J.; Vallero, R.O.; Schanen, N.C.; LaSalle, J.M. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J. Med. Genet. 2009, 46, 86-93.
31. Bertone, A.; Hanck, J.; Kogan, C.; Chaudhuri, A.; Cornish, K. Associating neural alterations and genotype in autism and fragile X syndrome: Incorporating perceptual phenotypes in causal modeling. J. Autism Dev. Disord. 2010, 40, 1541-1548.
32. Blatt, G.J.; Fatemi, S.H. Alterations in gabaergic biomarkers in the autism brain: Research findings and clinical implications. Anat. Rec. (Hoboken) 2011, 294, 1646-1652.
33. Fatemi, S.H.; Reutiman, T.J.; Folsom, T.D.; Rooney, R.J.; Patel, D.H.; Thuras, P.D. Mrna and protein levels for gabaaalpha4, alpha5, beta1 and gababr1 receptors are altered in brains from subjects with autism. J. Autism Dev. Disord. 2010, 40, 743-750.
34. Jamain, S.; Betancur, C.; Quach, H.; Philippe, A.; Fellous, M.; Giros, B.; Gillberg, C.; Leboyer, M.; Bourgeron, T. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry 2002, 7, 302-310.
35. Yang, Y.; Pan, C. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: A pilot study. Life Sci. 2013, 92, 149-153.
36. Fatemi, S.H.; Halt, A.R.; Stary, J.M.; Kanodia, R.; Schulz, S.C.; Realmuto, G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 2002, 52, 805-810.
37. Yip, J.; Soghomonian, J.J.; Blatt, G.J. Decreased GAD67 mrna levels in cerebellar purkinje cells in autism: Pathophysiological implications. Acta Neuropathol. 2007, 113, 559-568.
38. Shinohe, A.; Hashimoto, K.; Nakamura, K.; Tsujii, M.; Iwata, Y.; Tsuchiya, K.J.; Sekine, Y.; Suda, S.; Suzuki, K.; Sugihara, G.; et al. Increased serum levels of glutamate in adult patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30, 1472-1477.
39. Aldred, S.; Moore, K.M.; Fitzgerald, M.; Waring, R.H. Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 2003, 33, 93-97.
40. Ballaban-Gil, K.; Tuchman, R. Epilepsy and epileptiform EEG: Association with autism and language disorders. Ment. Retard. Dev. Disabil. Res. Rev. 2000, 6, 300-308.
41. Sutcliffe, J.S.; Delahanty, R.J.; Prasad, H.C.; McCauley, J.L.; Han, Q.; Jiang, L.; Li, C.; Folstein, S.E.; Blakely, R.D. Allelic heterogeneity at the serotonin transporter locus (slc6a4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 2005, 77, 265-279.
42. Levitt, P. Serotonin and the autisms: A red flag or a red herring? Arch. Gen. Psychiatry 2011, 68, 1093-1094.
43. Kumar, B.; Prakash, A.; Sewal, R.K.; Medhi, B.; Modi, M. Drug therapy in autism: A present and future perspective. Pharmacol. Rep. 2012, 64, 1291-1304.
44. Doyle, C.A.; McDougle, C.J. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin. Neurosci. 2012, 14, 263-279.
45. Posey, D.J.; Kem, D.L.; Swiezy, N.B.; Sweeten, T.L.; Wiegand, R.E.; McDougle, C.J. A pilot study of D-cycloserine in subjects with autistic disorder. Am. J. Psychiatry 2004, 161, 2115-2117.
46. Croen, L.A.; Grether, J.K.; Yoshida, C.K.; Odouli, R.; Hendrick, V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 2011, 68, 1104-1112.
47. Rai, D.; Lee, B.K.; Dalman, C.; Golding, J.; Lewis, G.; Magnusson, C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study. BMJ 2013, 346, doi: 10.1136/bmj.f2059.
48. McCracken, J.T.; McGough, J.; Shah, B.; Cronin, P.; Hong, D.; Aman, M.G.; Arnold, L.E.; Lindsay, R.; Nash, P.; Hollway, J.; et al. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 2002, 347, 314-321.
49. Nakamura, K.; Sekine, Y.; Ouchi, Y.; Tsujii, M.; Yoshikawa, E.; Futatsubashi, M.; Tsuchiya, K.J.; Sugihara, G.; Iwata, Y.; Suzuki, K.; et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatry 2010, 67, 59-68.
50. Kaluzna-Czaplinska, J.; Socha, E.; Rynkowski, J. Determination of homovanillic acid and vanillylmandelic acid in urine of autistic children by gas chromatography/mass spectrometry. Med. Sci. Monit. 2010, 16, CR445-CR450.
51. Hosenbocus, S.; Chahal, R. A review of executive function deficits and pharmacological management in children and adolescents. J. Can. Acad. Child. Adolesc. Psychiatry 2012, 21, 223-229.
52. Happe, F.; Booth, R.; Charlton, R.; Hughes, C. Executive function deficits in autism spectrum disorders and attention-deficit/hyperactivity disorder: Examining profiles across domains and ages. Brain Cogn. 2006, 61, 25-39.
53. Ernst, M.; Zametkin, A.J.; Matochik, J.A.; Pascualvaca, D.; Cohen, R.M. Low medial prefrontal dopaminergic activity in autistic children. Lancet 1997, 350, doi: 10.1016/S0140-6736(05)63326-0.
54. Buitelaar, J.K.; Willemsen-Swinkels, S.H. Medication treatment in subjects with autistic spectrum disorders. Eur. Child Adolesc. Psychiatry 2000, 9 (Suppl. 1), I85-I97.
55. Fukuto, T.R. Mechanism of action of organophosphorus and carbamate insecticides. Environ. Health Perspect. 1990, 87, 245-254.
56. Soreq, H.; Seidman, S. Acetylcholinesterase-New roles for an old actor. Nat. Rev. Neurosci. 2001, 2, 294-302.
57. Heusinkveld, H.J.; Westerink, R.H. Organochlorine insecticides lindane and dieldrin and their binary mixture disturb calcium homeostasis in dopaminergic pc12 cells. Environ. Sci. Technol. 2012, 46, 1842-1848.
58. Silva, M.H.; Beauvais, S.L. Human health risk assessment of endosulfan. I: Toxicology and hazard identification. Regul. Toxicol. Pharmacol. 2010, 56, 4-17.
59. Bemis, J.C.; Seegal, R.F. Polychlorinated biphenyls and methylmercury act synergistically to reduce rat brain dopamine content in vitro. Environ. Health Perspect. 1999, 107, 879-885.
60. Bemis, J.C.; Seegal, R.F. Pcb-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content. Toxicol. Sci. 2004, 80, 288-295.
61. Dreiem, A.; Okoniewski, R.J.; Brosch, K.O.; Miller, V.M.; Seegal, R.F. Polychlorinated biphenyls and polybrominated diphenyl ethers alter striatal dopamine neurochemistry in synaptosomes from developing rats in an additive manner. Toxicol. Sci. 2010, 118, 150-159.
62. Lyng, G.D.; Snyder-Keller, A.; Seegal, R.F. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum. Toxicol. Sci. 2007, 97, 128-139.
63. Yang, L.; Milutinovic, P.S.; Brosnan, R.J.; Eger, E.I., 2nd; Sonner, J.M. The plasticizer di(2-ethylhexyl) phthalate modulates gamma-aminobutyric acid type a and glycine receptor function. Anesth. Analg. 2007, 105, 393-396.
64. Tanida, T.; Warita, K.; Ishihara, K.; Fukui, S.; Mitsuhashi, T.; Sugawara, T.; Tabuchi, Y.; Nanmori, T.; Qi, W.M.; Inamoto, T.; et al. Fetal and neonatal exposure to three typical environmental chemicals with different mechanisms of action: Mixed exposure to phenol, phthalate, and dioxin cancels the effects of sole exposure on mouse midbrain dopaminergic nuclei. Toxicol. Lett. 2009, 189, 40-47.
65. Cabaleiro, T.; Caride, A.; Romero, A.; Lafuente, A. Effects of in utero and lactational exposure to endosulfan in prefrontal cortex of male rats. Toxicol. Lett. 2008, 176, 58-67.
66. Dickerson, S.M.; Cunningham, S.L.; Gore, A.C. Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus. Toxicol. Appl. Pharmacol. 2011, 252, 36-46.
67. Lafuente, A.; Cabaleiro, T.; Caride, A.; Gutierrez, A.; Esquifino, A.I. Toxic effects of methoxychlor in rat striatum: Modifications in several neurotransmitters. J. Physiol. Biochem. 2007, 63, 171-177.
68. Hilgier, W.; Lazarewicz, J.W.; Struzynska, L.; Frontczak-Baniewicz, M.; Albrecht, J. Repeated exposure of adult rats to Aroclor 1254 induces neuronal injury and impairs the neurochemical manifestations of the NMDA receptor-mediated intracellular signaling in the hippocampus. Neurotoxicology 2012, 33, 16-22.
69. Andersen, I.S.; Voie, O.A.; Fonnum, F.; Mariussen, E. Effects of methyl mercury in combination with polychlorinated biphenyls and brominated flame retardants on the uptake of glutamate in rat brain synaptosomes: A mathematical approach for the study of mixtures. Toxicol. Sci. 2009, 112, 175-184.
70. Struzynska, L.; Sulkowski, G.; Dabrowska-Bouta, B. Aroclor 1254 selectively inhibits expression of glial GLT-1 glutamate transporter in the forebrain of chronically exposed adult rat. Toxicology 2012, 300, 12-18.
71. Boix, J.; Cauli, O.; Felipo, V. Developmental exposure to polychlorinated biphenyls 52, 138 or 180 affects differentially learning or motor coordination in adult rats. Mechanisms involved. Neuroscience 2010, 167, 994-1003.
72. Boix, J.; Cauli, O.; Leslie, H.; Felipo, V. Differential long-term effects of developmental exposure to polychlorinated biphenyls 52, 138 or 180 on motor activity and neurotransmission. Gender dependence and mechanisms involved. Neurochem. Int. 2011, 58, 69-77.
73. Caudle, W.M.; Richardson, J.R.; Delea, K.C.; Guillot, T.S.; Wang, M.; Pennell, K.D.; Miller, G.W. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicol. Sci. 2006, 92, 490-499.
74. Honma, T.; Suda, M.; Miyagawa, M.; Wang, R.S.; Kobayashi, K.; Sekiguchi, S. Alteration of brain neurotransmitters in female rat offspring induced by prenatal administration of 16 and 64 mg/kg of 2,2',4,4',5,5'-hexachlorobiphenyl (pcb153). Ind. Health 2009, 47, 11-21.
75. Lafuente, A.; Cabaleiro, T.; Caride, A.; Esquifino, A.I. Toxic effects of methoxychlor administered subcutaneously on the hypothalamic-pituitary-testicular axis in adult rats. Food Chem. Toxicol. 2008, 46, 1570-1575.
76. Elnar, A.A.; Diesel, B.; Desor, F.; Feidt, C.; Bouayed, J.; Kiemer, A.K.; Soulimani, R. Neurodevelopmental and behavioral toxicity via lactational exposure to the sum of six indicator non-dioxin-like-polychlorinated biphenyls (summation operator6 ndl-pcbs) in mice. Toxicology 2012, 299, 44-54.
77. Pourabdolhossein, F.; Ghasemi, A.; Shahroukhi, A.; Sherafat, M.A.; Khoshbaten, A.; Asgari, A. In vitro assessment of paraoxon effects on GABA uptake in rat hippocampal synaptosomes. Toxicol. In Vitro 2009, 23, 868-873.
78. Mohammadi, M.; Ghani, E.; Ghasemi, A.; Khoshbaten, A.; Asgari, A. Synaptosomal GABA uptake decreases in paraoxon-treated rat brain. Toxicology 2008, 244, 42-48.
79. Noriega-Ortega, B.R.; Armienta-Aldana, E.; Cervantes-Pompa, J.A.; Hernandez-Ruiz, E.; Chaparro-Huerta, V.; Bravo-Cuellar, A.; Beas-Zarate, C. GABA and dopamine release from different brain regions in mice with chronic exposure to organophosphate methamidophos. J. Toxicol. Pathol. 2011, 24, 163-168.
80. Montes de Oca, L.; Moreno, M.; Cardona, D.; Campa, L.; Sunol, C.; Galofre, M.; Flores, P.; Sanchez-Santed, F. Long term compulsivity on the 5-choice serial reaction time task after acute chlorpyrifos exposure. Toxicol. Lett. 2013, 216, 73-85.
81. Rush, T.; Liu, X.Q.; Hjelmhaug, J.; Lobner, D. Mechanisms of chlorpyrifos and diazinon induced neurotoxicity in cortical culture. Neuroscience 2010, 166, 899-906.
82. Aldridge, J.E.; Meyer, A.; Seidler, F.J.; Slotkin, T.A. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 2005, 113, 1027-1031.
83. Chen, X.P.; Wang, X.; Dong, J.Y. Different reaction patterns of dopamine content to prenatal exposure to chlorpyrifos in different periods. J. Appl. Toxicol. 2011, 31, 355-359.
84. Eddins, D.; Cerutti, D.; Williams, P.; Linney, E.; Levin, E.D. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: Comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol. Teratol. 2010, 32, 99-108.
85. Eells, J.B.; Brown, T. Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels. Neurotoxicol. Teratol. 2009, 31, 98-103.
86. Moreno, M.; Canadas, F.; Cardona, D.; Sunol, C.; Campa, L.; Sanchez-Amate, M.C.; Flores, P.; Sanchez-Santed, F. Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure. Toxicol. Lett. 2008, 176, 162-167.
87. Sledge, D.; Yen, J.; Morton, T.; Dishaw, L.; Petro, A.; Donerly, S.; Linney, E.; Levin, E.D. Critical duration of exposure for developmental chlorpyrifos-induced neurobehavioral toxicity. Neurotoxicol. Teratol. 2011, 33, 742-751.
88. Lee, J.E.; Park, J.H.; Shin, I.C.; Koh, H.C. Reactive oxygen species regulated mitochondria-mediated apoptosis in pc12 cells exposed to chlorpyrifos. Toxicol. Appl. Pharmacol. 2012, 263, 148-162.
89. Binukumar, B.K.; Bal, A.; Kandimalla, R.J.; Gill, K.D. Nigrostriatal neuronal death following chronic dichlorvos exposure: Crosstalk between mitochondrial impairments, alpha synuclein aggregation, oxidative damage and behavioral changes. Mol. Brain 2010, 3, 35, doi:10.1186/1756-6606-3-35
90. Binukumar, B.K.; Gupta, N.; Bal, A.; Gill, K.D. Protection of dichlorvos induced oxidative stress and nigrostriatal neuronal death by chronic coenzyme q10 pretreatment. Toxicol. Appl. Pharmacol. 2011, 256, 73-82.
91. Slotkin, T.A.; Seidler, F.J. Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats. Brain Res. Bull. 2007, 73, 301-309.
92. Slotkin, T.A.; Seidler, F.J. Prenatal chlorpyrifos exposure elicits presynaptic serotonergic and dopaminergic hyperactivity at adolescence: Critical periods for regional and sex-selective effects. Reprod. Toxicol. 2007, 23, 421-427.
93. Xu, L.; Tian, H.; Wang, W.; Ru, S. Effects of monocrotophos pesticide on serotonin metabolism during early development in the sea urchin, hemicentrotus pulcherrimus. Environ. Toxicol. Pharmacol. 2012, 34, 537-547.
94. Carbone, S.; Samaniego, Y.A.; Cutrera, R.; Reynoso, R.; Cardoso, N.; Scacchi, P.; Moguilevsky, J.A.; Ponzo, O.J. Different effects by sex on hypothalamic-pituitary axis of prepubertal offspring rats produced by in utero and lactational exposure to di-(2-ethylhexyl) phthalate (dehp). Neurotoxicology 2012, 33, 78-84.
95. Carbone, S.; Szwarcfarb, B.; Ponzo, O.; Reynoso, R.; Cardoso, N.; Deguiz, L.; Moguilevsky, J.A.; Scacchi, P. Impact of gestational and lactational phthalate exposure on hypothalamic content of amino acid neurotransmitters and fsh secretion in peripubertal male rats. Neurotoxicology 2010, 31, 747-751.
96. Ishido, M.; Masuo, Y.; Sayato-Suzuki, J.; Oka, S.; Niki, E.; Morita, M. Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J. Neurochem. 2004, 91, 69-76.
97. Tanaka, M.; DeLorey, T.M.; Delgado-Escueta, A.; Olsen, R.W. Gabrb3, Epilepsy, and Neurodevelopment. In Source Jasper's Basic Mechanisms of the Epilepsies [Internet]; Noebels, J.L., Avoli, M., Rogawski, M.A., Olsen, R.W., Delgado-Escueta, A.V., Eds.; National Center for Biotechnology Information: Bethesda, MD, USA, 2012.
98. Damodaran, T.V.; Patel, A.G.; Greenfield, S.T.; Dressman, H.K.; Lin, S.M.; Abou-Donia, M.B. Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem. Pharmacol. 2006, 71, 497-520.
99. Slotkin, T.A.; Ryde, I.T.; Levin, E.D.; Seidler, F.J. Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: Effects on serotonin systems in adolescence and adulthood. Brain Res. Bull. 2008, 75, 640-647.
100. Richardson, J.R.; Caudle, W.M.; Wang, M.; Dean, E.D.; Pennell, K.D.; Miller, G.W. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of parkinson's disease. FASEB J. 2006, 20, 1695-1697.
101. Padilla, S.; Marshall, R.S.; Hunter, D.L.; Oxendine, S.; Moser, V.C.; Southerland, S.B.; Mailman, R.B. Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats. Toxicol. Sci. 2005, 88, 161-171.
102. Lee, D.W.; Opanashuk, L.A. Polychlorinated biphenyl mixture aroclor 1254-induced oxidative stress plays a role in dopaminergic cell injury. Neurotoxicology 2004, 25, 925-939.
103. Richardson, J.R.; Miller, G.W. Acute exposure to Aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicol. Lett. 2004, 148, 29-40.
104. Gerfen, C.R.; Miyachi, S.; Paletzki, R.; Brown, P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 2002, 22, 5042-5054.
105. Hatcher, J.M.; Richardson, J.R.; Guillot, T.S.; McCormack, A.L.; Di Monte, D.A.; Jones, D.P.; Pennell, K.D.; Miller, G.W. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp. Neurol. 2007, 204, 619-630.
106. Cannon, J.R.; Greenamyre, J.T. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol. Sci. 2011, 124, 225-250.
107. Bardin, P.G.; van Eeden, S.F.; Moolman, J.A.; Foden, A.P.; Joubert, J.R. Organophosphate and carbamate poisoning. Arch. Intern. Med. 1994, 154, 1433-1441.
108. Collombet, J.M. Nerve agent intoxication: Recent neuropathophysiological findings and subsequent impact on medical management prospects. Toxicol. Appl. Pharmacol. 2011, 255, 229-241.
109. Hayden, K.M.; Norton, M.C.; Darcey, D.; Ostbye, T.; Zandi, P.P.; Breitner, J.C.; Welsh-Bohmer, K.A. Occupational exposure to pesticides increases the risk of incident AD: The cache county study. Neurology 2010, 74, 1524-1530
110. Landrigan, P.J.; Sonawane, B.; Mattison, D.; McCally, M.; Garg, A. Chemical contaminants in breast milk and their impacts on children's health: An overview. Environ. Health Perspect. 2002, 110, A313-A315.
111. Seegal, R.F.; Brosch, K.O.; Okoniewski, R.J. Coplanar PCB congeners increase uterine weight and frontal cortical dopamine in the developing rat: Implications for developmental neurotoxicity. Toxicol. Sci. 2005, 86, 125-131.
112. Ghasemi, A.; Sadidi, A.; Mohammadi, M.; Khoshbaten, A.; Asgari, A. Paraoxon inhibits GABA uptake in brain synaptosomes. Toxicol. In Vitro 2007, 21, 1499-1504.
113. Vandenberg, L.N.; Colborn, T.; Hayes, T.B.; Heindel, J.J.; Jacobs, D.R., Jr.; Lee, D.H.; Shioda, T.; Soto, A.M.; vom Saal, F.S.; Welshons, W.V.; et al. Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33, 378-455.
114. Liu, S.V.; Schally, A.V.; Hawes, D.; Xiong, S.; Fazli, L.; Gleave, M.; Cai, J.; Groshen, S.; Brands, F.; Engel, J.; et al. Expression of receptors for luteinizing hormone-releasing hormone (lh-rh) in prostate cancers following therapy with lh-rh agonists. Clin. Cancer Res. 2010, 16, 4675-4680.
115. Piccart, M.; Parker, L.M.; Pritchard, K.I. Oestrogen receptor downregulation: An opportunity for extending the window of endocrine therapy in advanced breast cancer. Ann. Oncol. 2003, 14, 1017-1025.